Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acids and Conjugates [FA01]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA02010025 14,15-dehydro-12-oxo-phytodienoic acid 8-[(5E)-4-oxo-5-[(Z)-pent-2-enylidene]cyclopent-2-en-1-yl]octanoic acid FA 18:5;O C18H26O3 290.188195
LMFA02010025 14,15-dehydro-12-oxo-phytodienoic acid 8-[(5E)-4-oxo-5-[(Z)-pent-2-enylidene]cyclopent-2-en-1-yl]octanoic acid FA 18:5;O C18H26O3 290.188195
LMFA02010025 14,15-dehydro-12-oxo-phytodienoic acid 8-[(5E)-4-oxo-5-[(Z)-pent-2-enylidene]cyclopent-2-en-1-yl]octanoic acid FA 18:5;O C18H26O3 290.188195
LMFA01050601 9-Hydroxy-6Z-nonenoic acid 9-Hydroxy-6Z-nonenoic acid FA 9:1;O C9H16O3 172.109945
LMFA01170145 18-hydroxy-18-oxo-dinorleukotriene B4 (4Z,7R,8E,10E,12Z,14S)-7,14-dihydroxyoctadeca-4,8,10,12-tetraenedioic acid FA 18:5;O4 C18H26O6 338.172940
LMFA01170145 18-hydroxy-18-oxo-dinorleukotriene B4 (4Z,7R,8E,10E,12Z,14S)-7,14-dihydroxyoctadeca-4,8,10,12-tetraenedioic acid FA 18:5;O4 C18H26O6 338.172940
LMFA03020086 Tauro-18-carboxy-19,20-dinorleukotriene B4 5S,12R-dihydroxy-18-oxo-18-(2-sulfoethylamino)octadeca-6Z,8E,10E,14Z-tetraenoic acid C20H31NO8S 445.177041
LMFA03020086 Tauro-18-carboxy-19,20-dinorleukotriene B4 5S,12R-dihydroxy-18-oxo-18-(2-sulfoethylamino)octadeca-6Z,8E,10E,14Z-tetraenoic acid C20H31NO8S 445.177041
LMFA02000408 8-(2-butyl-6R-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000408 8-(2-butyl-6R-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000408 8-(2-butyl-6R-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000409 8-(2-butyl-6S-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000409 8-(2-butyl-6S-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000409 8-(2-butyl-6S-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000410 7-(5S-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000410 7-(5S-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000410 7-(5S-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000411 7-(5R-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000411 7-(5R-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA02000411 7-(5R-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid FA 18:3;O2 C18H30O4 310.214410
LMFA07100004 Pantheric acid D 8-methoxy-2methylene-8-oxooctanoic acid SFE 10:2;O2 C10H16O4 200.104860
LMFA07100005 Pantheric acid E 8-ethoxy-2methylene-8-oxooctanoic acid SFE 11:2;O2 C11H18O4 214.120510
LMFA07100006 Pantheric acid F 10-ethoxy-2methylene-10-oxodecanoic acid SFE 13:2;O2 C13H22O4 242.151810
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140107 Alutacenoic acid A 6-(3-oxocyclopropen-1-yl)hexanoic acid FA 9:3;O C9H12O3 168.078645
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA01140108 Alutacenoic acid B 8-(3-oxocyclopropen-1-yl)octanoic acid FA 11:3;O C11H16O3 196.109945
LMFA01150073 (+)-petromyric acid A (2S,3S,5R)-tetrahydro-3-hydroxy-5-[(1R)-1-hydroxyhexyl]-2-furanoctanoic acid FA 18:1;O3 C18H34O5 330.240625
LMFA01050602 2R-hydroxy-goshuyic acid 2R-hydroxy-5Z,8Z-tetradecadienoic acid FA 14:2;O C14H24O3 240.172545
LMFA07100007 methyl-2R-hydroxy-goshuyic acid methyl 2R-hydroxy-5Z,8Z-tetradecadienoate SFE 15:2;O C15H26O3 254.188195
LMFA07100007 methyl-2R-hydroxy-goshuyic acid methyl 2R-hydroxy-5Z,8Z-tetradecadienoate SFE 15:2;O C15H26O3 254.188195
LMFA01140109 Tripmycin A 13-(2-methylphenyl)-12E-tridecenoic acid FA 20:5 C20H30O2 302.224580
LMFA01140110 5-(2-Methylphenyl)-4-pentenoic acid FA 12:5 C12H14O2 190.099380
LMFA03010151 PGE2-EA N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010151 PGE2-EA N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010151 PGE2-EA N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010075 PGF2alpha-EA N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine NAE 20:3;O3 C22H39NO5 397.282824
LMFA03010075 PGF2alpha-EA N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine NAE 20:3;O3 C22H39NO5 397.282824
LMFA03010152 PGD2-EA N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010152 PGD2-EA N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA03010152 PGD2-EA N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine NAE 20:4;O3 C22H37NO5 395.267174
LMFA01050603 20-HEPE (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic acid FA 20:5;O C20H30O3 318.219495
LMFA01050604 22-HDHA 22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid FA 22:6;O C22H32O3 344.235145
LMFA07070120 3S,7Z-hydroxytetradecenoylcarnitine 3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:1;O C21H39NO5 385.282824
LMFA07070120 3S,7Z-hydroxytetradecenoylcarnitine 3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 14:1;O C21H39NO5 385.282824
LMFA07070121 3S,5Z-hydroxydodecenoylcarnitine 3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 12:1;O C19H35NO5 357.251524
LMFA07070121 3S,5Z-hydroxydodecenoylcarnitine 3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate CAR 12:1;O C19H35NO5 357.251524
LMFA07070122 2E,9Z-Hexadecadienoylcarnitine 3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070122 2E,9Z-Hexadecadienoylcarnitine 3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 16:2 C23H41NO4 395.303559
LMFA07070123 2E,7Z-tetradecadienoylcarnitine 3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate CAR 14:2 C21H37NO4 367.272259